Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02246634

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
282 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Eligible patients with high risk colorectal malignancy (T3/4, spread greater than 5mm, EMVI positive) will have additional surveillance of breath hold T1, T2 and DW-MRIs (no IV contrast) post surgery six monthly for three years. Findings of liver MRIs as reported by radiology PI will be shared with their local MDT who make decisions as appropriate, including the management of any identified liver metastases, according to local protocol.

Detailed description

A phase II multicentre, interventional study to determine if additional staging at diagnosis with liver DW-MRI will diagnose more synchronous metastases than CT alone in patients with high risk colorectal cancer. Liver metastases found on the additional DW-MRI scans will be discussed at MDT and treated according to local policy.

Conditions

Interventions

TypeNameDescription
OTHERDiffusion Weighted MRI scanLiver metastases found on the additional DW-MRI scans will be discussed at MDT and treated according to local site policy.

Timeline

Start date
2014-08-01
Primary completion
2026-12-01
Completion
2031-12-01
First posted
2014-09-23
Last updated
2024-10-17

Locations

13 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02246634. Inclusion in this directory is not an endorsement.